Microbot Medical Inc. MBOT
Medical/Dental Instruments · data as of November 13, 2026
Microbot Medical Inc. (MBOT) is a healthcare company listed in the US with a market value of about $66M.
Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -125%.
About Microbot Medical
Microbot Medical is listed in the US and classified in medical/dental instruments. It was profitable in 0 of the last 10 years in our data. Its share count rose by 531% over three years (dilution for shareholders).
Score: 0.4 / 5
Checks passed
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — |
| Net income | -$13M | -$11M | -$11M | -$13M | -$11M | -$9M | -$7M | -$7M | -$8M | -$10M |
| Free cash flow | -$13M | -$9M | -$9M | -$12M | -$9M | -$7M | -$7M | -$6M | -$5M | -$811000 |
| EPS (diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | $-1.59 | $-1.29 | $-1.70 | $-2.41 | $-2.76 | $6.00 |
| Net margin | — | — | — | — | — | — | — | — | — | — |
| ROIC | -14.8% | -252.2% | -164.5% | -135.4% | -59.6% | -28.6% | -17.6% | -430.3% | 41.6% | -204.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $5.38, 449% above the current price; targets range from $2.50 to $12.00; the consensus rating is “none”; expected EPS is $-0.30 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Microbot Medical pay a dividend?
Not currently.
Is Microbot Medical a good stock to buy?
We do not give buy or sell advice. Microbot Medical scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.